SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-009605
Filing Date
2024-04-01
Accepted
2024-04-01 18:48:55
Documents
1
Period of Report
2024-03-28

Document Format Files

Seq Description Document Type Size
1 form4-04012024_100439.html 4  
1 form4-04012024_100439.xml 4 4441
  Complete submission text file 0001415889-24-009605.txt   5978
Mailing Address NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
RIEFLIN WILLIAM JL (Reporting) CIK: 0001182471 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 24811628

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)